AI Article Synopsis

  • Glioblastoma multiforme (GBM) is a highly aggressive brain tumor categorized as Grade 4 by the WHO, with established risk factors including genetic syndromes, body mass index, and certain medications.
  • Vascular issues such as thrombosis are common in GBM, and podoplanin (PDPN) plays a significant role in tumor progression by enhancing platelet activity and cancer cell metastasis.
  • PDPN is suggested as an independent prognostic factor for GBM, as its expression is linked to worse outcomes, with recent studies indicating its involvement in the development of more aggressive cancer stem cells.

Article Abstract

Glioblastoma multiforme (GBM) is a malignant primary brain tumor categorized as a Grade 4 astrocytic glioma by the World Health Organization (WHO). Some of the established risk factors of GBM include inherited genetic syndromes, body mass index, alcohol consumption, use of non-steroidal anti-inflammatory drugs (NSAIDs), and therapeutic ionizing radiation. Vascular anomalies, including local and peripheral thrombosis, are common features of GBM. Podoplanin (PDPN), a ligand of the C-type lectin receptor (CLEC-2), promotes platelet activation, aggregation, venous thromboembolism (VTE), lymphatic vessel formation, and tumor metastasis in GBM patients. It is regulated by Prox1 and is expressed in developing and adult mammalian brains. It was initially identified on lymphatic endothelial cells (LECs) as the E11 antigen and on fibroblastic reticular cells (FRCs) of lymphoid organs and thymic epithelial cells as gp38. In recent research studies, its expression has been linked with prognosis in GBM. PDPN-expressing cancer cells are highly pernicious, with a mutant aptitude to form stem cells. Such cells, on colocalization to the surrounding tissues, transition from epithelial to mesenchymal cells, contributing to the malignant carcinogenesis of GBM. PDPN can be used as an independent prognostic factor in GBM, and this review provides strong preclinical and clinical evidence supporting these claims.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11639870PMC
http://dx.doi.org/10.3390/cancers16234051DOI Listing

Publication Analysis

Top Keywords

podoplanin pdpn
8
glioblastoma multiforme
8
gbm
8
multiforme gbm
8
cells
7
role podoplanin
4
pdpn advancing
4
advancing progression
4
progression metastasis
4
metastasis glioblastoma
4

Similar Publications

Purpose: Oral squamous cell carcinoma (OSCC) is a significant public health challenge associated with high mortality rates primarily due to its invasive and metastatic behavior. This study aimed to evaluate the expression patterns of five critical biomarkers: β-catenin, E-cadherin, podoplanin (PDPN), CXCR4, and p53 in OSCC tissues and to investigate their correlations with clinicopathologic features and patient outcomes.

Methods: We conducted an immunohistochemical analysis utilizing tissue microarrays (TMAs) from 95 patients diagnosed with primary OSCC.

View Article and Find Full Text PDF

Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen.

Cells

December 2024

Division of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.

Membrane proteins, especially extracellular domains, are key therapeutic targets due to their role in cell communication and associations. Yet, their functions and interactions often remain unclear. This study presents a general method to discover interactions of membrane proteins with immune cells and subsequently to deorphanize their respective receptors.

View Article and Find Full Text PDF

Cancer-associated fibroblasts (CAFs) are intrinsic components of the tumor microenvironment that promote cancer progression and metastasis. Through an unbiased integrated analysis of gastric tumor grade and stage, we identified a subset of proangiogenic CAFs characterized by high podoplanin (PDPN) expression, which are significantly enriched in metastatic lesions and secrete chemokine (CC-motif) ligand 2 (CCL2). Mechanistically, PDPN(+) CAFs enhance angiogenesis by activating the AKT/NF-κB signaling pathway.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma multiforme (GBM) is a highly aggressive brain tumor categorized as Grade 4 by the WHO, with established risk factors including genetic syndromes, body mass index, and certain medications.
  • Vascular issues such as thrombosis are common in GBM, and podoplanin (PDPN) plays a significant role in tumor progression by enhancing platelet activity and cancer cell metastasis.
  • PDPN is suggested as an independent prognostic factor for GBM, as its expression is linked to worse outcomes, with recent studies indicating its involvement in the development of more aggressive cancer stem cells.
View Article and Find Full Text PDF

Background And Aim: Head and neck paragangliomas (HNPGN) are tumours that carry significant morbidity The role of the stroma in the pathogenesis of HNPGN is not completely understood. This study explores the profile of fibroblasts and macrophages in HNPGN.

Methods: Ten patients undergoing HNPGN surgery were recruited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!